PHIA FINANCIAL STATEMENTS

Koninklijke Philips NV — balance sheet, income statement and cash flow trends

PHIAKoninklijke Philips NV

🇳🇱 Netherlands · AS · Healthcare · Medical Devices

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue17.6 B €-1.9%

Gross Profit8 B €+2.1%

Operating Income1.6 B €+5.2%

EBITDA2.7 B €+328.7%

Net Income970 M €+160.1%

Peer Comparison· Medical Devices

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
PHIA	-1.9%	45.2%	15.4%	5.5%
DXCM	16.1%	61.8%	30.6%	19.3%
GEHC	0.8%	42.5%	17.0%	7.5%
STE	8.7%	44.2%	30.8%	13.2%
ZBH	9.2%	70.0%	26.2%	9.1%
SHL	-0.3%	38.0%	19.1%	9.1%
Industry median	7.4%	58.9%	5.2%	-5.7%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity11.4 B €42%
Current Liabilities7.4 B €27%
Long-term Liabilities8.4 B €31%

Key Figures

YoY change

Total Assets27.3 B €+0.4%

Total Liabilities15.8 B €+2.6%

Total Equity11.4 B €-2.6%

Cash & ST Investments2.6 B €+116.9%

Total Debt8.1 B €+7.0%

Net Debt5.5 B €-13.7%

Peer Comparison· Medical Devices

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
PHIA	1.32	71.1%	2.03	41.8%
DXCM	1.95	46.8%	-0.70	44.6%
GEHC	1.17	99.1%	2.44	28.7%
STE	2.09	29.1%	0.90	66.9%
ZBH	1.73	59.0%	3.19	55.8%
SHL	1.10	84.1%	3.04	40.6%
Industry median	3.28	44.7%	0.82	49.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow2.3 B €+184.1%

Capital Expenditures383 M €-53.6%

Free Cash Flow1.9 B €+1,254.6%

Dividends Paid-328 M €-32,900.0%

Peer Comparison· Medical Devices

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
PHIA	13.0%	10.8%	2.2%	236.4%
DXCM	37.0%	29.7%	7.3%	191.6%
GEHC	10.2%	7.6%	2.5%	134.8%
STE	22.6%	16.4%	6.2%	171.4%
ZBH	19.9%	21.8%	4.7%	219.8%
SHL	12.2%	8.7%	3.5%	134.0%
Industry median	7.2%	1.5%	4.1%	76.6%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on PHIA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.